No findings of dental defects in children treated with minocycline

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 7, 2004, Pages 2739-2741

  Cascio, Antonio ^a,b   Di Liberto, Chiara ^a   D'Angelo, Matteo ^a   Iaria, Chiara ^b   Scarlata, Francesco ^a   Titone, Lucina ^a   Campisi, Giuseppina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; RIFAMPICIN; TETRACYCLINE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BRUCELLOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG INDICATION; DRUG SCREENING; DRUG UTILIZATION; ENAMEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TOOTH COLOR; TOOTH DISEASE;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; BRUCELLOSIS; CHILD; CHILD, PRESCHOOL; DENTAL ENAMEL; HUMANS; MINOCYCLINE; RETROSPECTIVE STUDIES; RIFAMPIN; TOOTH DISEASES;

EID: 3042570451     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.7.2739-2741.2004     Document Type: Article

References (12)

1. American Academy of Pediatrics. 2003. Rocky Mountain spotted fever, p. 452-454. In G. Peter (ed.), Report of the committee on infectious diseases, 26th ed. American Academy of Pediatrics, Elk Grove Village, Ill.
2. Angelillo, I. F., F. Romano, L. Fortunato, and D. Montanaro. 1990. Prevalence of dental caries and enamel defects in children living in areas with different water fluoride concentrations. Community Dent. Health 7:229-236.
3. Brearley, L. J., and E. Storey. 1968. Tetracycline-induced tooth changes. Prevalence, localization and nature of staining in extracted deciduous teeth. Med. J. Aust. 2:714-719.
4. Cascio, A., F. Scarlata, S. Giordano, S. Antinori, C. Colomba, and L. Titone. 2003. Treatment of human brucellosis with rifampin plus minocycline. J. Chemother. 15:266-270.
5. Cawson, R. A., W. H. Binnie, A. W. Barrett, and J. M. Wright. 2001. Developmental defects of the teeth, p. 2-10. In Oral disease, 3rd ed. Mosby, London, United Kingdom.
6. Commission on Oral Health, Research and Epidemiology. 1982. An epidemiological index of developmental defects of dental enamel (DDE Index). Int. Dent. J. 32:159-167.
7. Eady, E. A., J. H. Cove, K. T. Holland, and W. J. Cunliffe. 1990. Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br. J. Dermatol. 122:233-244.
8. Grossman, E. R., A. Walchek, and H. Freedman. 1971. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics 47:567-570.
9. Jawetz, E. 1989. Chloramphenicol and tetracycline, p. 568-575. In B. Katzung (ed.), Basic and clinical pharmacology, 4th ed. Appleton and Lange, Norwalk, Conn.
10. Klein, N. C., and B. A. Cunha. 1995. Tetracyclines. Med. Clin. North Am. 79:789-801.
11. Rang, H. P., M. M. Dale, and J. M. Ritter. 1995. Pharmacology, 3rd ed., p. 718-743. Churchill Livingstone, New York, N.Y.
12. Saivin, S., and G. Houin. 1988. Clinical pharmacokinetics of doxycycline and minocycline. Clin. Pharmacokinet. 15:355-366.